Guardant Health, Inc.
For the period ended Nov 5, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 5, 2026 · Filed Nov 5, 2026
Use the contents to explore the available documents and sections.
GH$150.87-1.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenue | $360,975 | $265,196 | $997,618 | $700,755 |
| Costs and operating expenses: | ||||
| Cost of revenue | 124,822 | 93,587 | 345,690 | 249,515 |
| Research and development expense | 100,838 | 89,957 | 288,409 | 265,927 |
| Sales and marketing expense | 177,218 | 127,375 | 536,304 | 351,279 |
| General and administrative expense | 90,862 | 53,266 | 210,448 | 150,477 |
| Total costs and operating expenses | 493,740 | 364,185 | 1,380,851 | 1,017,198 |
| Loss from operations | (132,765) | (98,989) | (383,233) | (316,443) |
| Interest income | 9,749 | 7,391 | 31,099 | 24,063 |
| Interest expense | (1,345) | (943) | (4,038) | (2,717) |
| Other income (expense), net | 342 | (48) | 493 | 7,778 |
| Loss before provision for income taxes | (124,019) | (92,589) | (355,679) | (287,319) |
| Provision for income taxes | 343 | 136 | 900 | 464 |
| Net loss | $(124,362) | $(92,725) | $(356,579) | $(287,783) |
| Net loss per share, basic and diluted | $(0.93) | $(0.74) | $(2.68) | $(2.32) |
| Weighted-average shares used in computing net loss per share, basic and diluted | 134,422 | 124,807 | 132,866 | 124,268 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.